NSC 696807 is primarily investigated for its potential in cancer research. It has shown promise in preclinical studies as an inhibitor of specific pathways involved in tumor growth and survival. Researchers are exploring its ability to disrupt cellular processes that are critical for cancer cell proliferation, making it a candidate for further development in targeted cancer therapies. Additionally, its role in inducing apoptosis in certain cancer cell lines has garnered attention, suggesting potential applications in chemotherapy. Ongoing studies aim to evaluate its efficacy, safety, and potential combination with other treatments to enhance therapeutic outcomes.